GENELUX Corp
Qualité des données : 100%
GNLX
Nasdaq
Manufacturing
Chemicals
2,41 €
▼
0,24 €
(-8,90%)
Cap. Boursière: 107,76 M
Prix
2,41 €
Cap. Boursière
107,76 M
Fourchette du Jour
2,31 € — 2,89 €
Fourchette 52 Semaines
2,21 € — 8,54 €
Volume
816 234
Ouverture 2,72 €
Moyenne 50J / 200J
2,64 €
8,96% below
Moyenne 50J / 200J
3,85 €
37,57% below
Quick Summary
Points Clés
Negative free cash flow of -26,37 M
Capital intensive — 13725,00% of revenue goes to capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)0,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-151,31%
En dessous de la moyenne du secteur (-53,41%)
ROIC-116,31%
Net Margin-401812,50%
Op. Margin-415175,00%
Sécurité
Debt / Equity
N/A
Current Ratio4,20
Interest CoverageN/A
Valorisation
PE (TTM)
-3,35
En dessous de la moyenne du secteur (-1,48)
P/B Ratio5,80
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,4 | -1,5 |
| P/B | 5,8 | 1,6 |
| ROE % | -151,3 | -53,4 |
| Net Margin % | -401812,5 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
ETFs Holding This Stock
0,00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,00% | Revenue Growth (3Y) | -78,31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 8 000,0 | Net Income (TTM) | -32,15 M |
| ROE | -151,31% | ROA | -112,33% |
| Gross Margin | N/A | Operating Margin | -415175,00% |
| Net Margin | -401812,50% | Free Cash Flow (TTM) | -26,37 M |
| ROIC | -116,31% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4,20 |
| Interest Coverage | N/A | Asset Turnover | 0,00 |
| Working Capital | 16,43 M | Tangible Book Value | 18,59 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3,35 | Forward P/E | N/A |
| P/B Ratio | 5,80 | P/S Ratio | 13469,75 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -24,47% | ||
| Market Cap | 107,76 M | Enterprise Value | 107,76 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,86 | Revenue / Share | 0,00 |
| FCF / Share | -0,59 | OCF / Share | -0,56 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 13725,00% | FCF Conversion | 82,02% |
| SBC-Adj. FCF | -32,22 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 8 000,0 | 8 000,0 | 170 000,0 |
| Net Income | -32,15 M | -29,87 M | -28,30 M |
| EPS (Diluted) | -0,86 | -0,95 | -1,16 |
| Gross Profit | — | — | — |
| Operating Income | -33,21 M | -31,70 M | -24,17 M |
| EBITDA | — | — | — |
| R&D Expenses | 19,85 M | 19,00 M | 12,77 M |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | — | 173 000,0 | — |
| Income Tax | — | — | 1,10 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 19,03 M | 34,72 M | 27,89 M |
| Total Liabilities | 7,48 M | 8,44 M | 8,42 M |
| Shareholders' Equity | 11,54 M | 26,27 M | 19,47 M |
| Total Debt | — | 900 000,0 | 900 000,0 |
| Cash & Equivalents | 5,33 M | 8,57 M | 9,42 M |
| Current Assets | 15,13 M | 31,55 M | 24,20 M |
| Current Liabilities | 6,23 M | 6,90 M | 6,55 M |
{"event":"ticker_viewed","properties":{"ticker":"GNLX","listing_kind":"stock","pathname":"/stocks/gnlx","exchange":"Nasdaq","country":"US"}}
